Literature DB >> 2613807

Determination of bromperidol in serum by automated column-switching high-performance liquid chromatography.

K Hikida1, Y Inoue, T Miyazaki, N Kojima, Y Ohkura.   

Abstract

A column-switching high-performance liquid chromatographic method with ultraviolet detection is described for the simple and rapid determination of bromperidol, a neuroleptic drug, in dog and human sera. The drug in serum and trifluperidol added to the serum as an internal standard were extracted with hexane-chloroform, and the extract was subjected to automated column-switching high-performance liquid chromatography using a hydrophilic metaacrylate polymer column (TSK gel PW precolumn) for sample clean-up and a reversed-phase column (TSK gel ODS-80TM) for separation. The detection limit of bromperidol is 0.3 ng/ml serum and the recovery of bromperidol added to serum (2.7-16.0 ng/ml) was satisfactory with a standard deviation of 3% or less.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2613807     DOI: 10.1016/s0378-4347(00)82624-9

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.

Authors:  E Suzuki; S Kanba; H Koshikawa; M Nibuya; G Yagi; M Asai
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

2.  Drug interaction between St John's Wort and quazepam.

Authors:  Atsuhiro Kawaguchi; Masami Ohmori; Shu-Ichi Tsuruoka; Kenta Nishiki; Kenichi Harada; Isamu Miyamori; Ryo-Ichi Yano; Toshiaki Nakamura; Mikio Masada; Akio Fujimura
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

3.  Long-term imipramine treatment increases nitrate levels in the rat hypothalamus.

Authors:  Eiji Suzuki; Toshio Nakaki; Shigenobu Kanba; Futoshi Shintani; Hitoshi Miyaoka
Journal:  Cell Mol Neurobiol       Date:  2003-12       Impact factor: 5.046

4.  Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia.

Authors:  Norio Yasui-Furukori; Tsuyoshi Kondo; Kazuo Mihara; Yoshimasa Inoue; Sunao Kaneko
Journal:  Psychopharmacology (Berl)       Date:  2003-09-04       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.